Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome‐wide expression analysis and game theory
- 31 July 2008
- Vol. 113 (6) , 1412-1422
- https://doi.org/10.1002/cncr.23720
Abstract
BACKGROUND.: Neuroblastic tumors (NTs) are largely comprised of neuroblastic (Nb) cells with various quantities of Schwannian stromal (SS) cells. NTs show a variable genetic heterogeneity. NT gene expression profiles reported so far have not taken into account the cellular components. The authors reported the genome‐wide expression analysis of whole tumors and microdissected Nb and SS cells.METHODS.: The authors analyzed gene expression profiles of 10 stroma‐poor NTs (NTs‐SP) and 9 stroma‐rich NTs (NTs‐SR) by microarray technology. Nb and SS cells were isolated by laser microdissection from NTs‐SP and NTs‐SR and probed with microarrays. Gene expression data were analyzed by the Significance Analysis of Microarrays (SAM) and Game Theory (GT) methods, the latter applied for the first time to microarray data evaluation.RESULTS.: SAM identified 84 genes differentially expressed between NTs‐SP and NTs‐SR, whereas 50 were found by GT. NTs‐SP mainly express genes associated with cell replication, nervous system development, and antiapoptotic pathways, whereas NTs‐SR express genes of cell‐cell communication and apoptosis. Combining SAM and GT, the authors found 16 common genes driving the separation between NTs‐SP and NTs‐SR. Five genes overexpressed in NTs‐SP encode for nuclear proteins (CENPF, EYA1, PBK, TOP2A, TFAP2B), whereas only 1 of 11 highly expressed genes in NTs‐SR encodes for a nuclear receptor (NR4A2).CONCLUSIONS.: The results showed that NT‐SP and NT‐SR gene signatures differ for a set of genes involved in distinct pathways, and the authors demonstrated a low intratumoral heterogeneity at the mRNA level in both NTs‐SP and NTs‐SR. The combination of SAM and GT methods may help to better identify gene expression profiling in NTs. Cancer 2008. © 2008 American Cancer Society.Keywords
This publication has 33 references indexed in Scilit:
- Topotecan and Etoposide in the Treatment of Relapsed High-risk NeuroblastomaJournal of Pediatric Hematology/Oncology, 2007
- Translocations of 17q21∼qter in neuroblastoma cell lines infrequently include the topoisomerase IIα geneCancer Genetics and Cytogenetics, 2006
- Altered expression of cell cycle genes distinguishes aggressive neuroblastomaOncogene, 2004
- Gene expression profiling and identification of novel prognostic marker genes in neuroblastomaGenes, Chromosomes and Cancer, 2004
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological FunctionsEndocrine Reviews, 2001
- High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastomaOncogene, 2000
- Protease Activation in Apoptosis Induced by MALExperimental Cell Research, 1999
- Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell linesGenes, Chromosomes and Cancer, 1998
- Statistical "Discoveries" and Effect-Size EstimationJournal of the American Statistical Association, 1989